Pain blocker
The experimental drug filgotinib blocks a set of enzymes that cause inflammation in rheumatoid arthritis patients who haven’t benefitted from other treatments, a study shows.
The experimental drug filgotinib blocks a set of enzymes that cause inflammation in rheumatoid arthritis patients who haven’t benefitted from other treatments, a study shows.
How Stanford physicians and researchers prepare patients to thrive after surgery
Researchers hope discovery of brain cells that make pain unpleasant can lead to treatments for chronic pain patients
Knowing the genetic makeup of tissue that forms around organs after surgery could prevent the painful adhesions.
Readmit
People who have physical therapy soon after a diagnosis for shoulder, back and other musculoskeletal pain are less likely to use opioids, an analysis shows.
Figuring out why some pain becomes agonizing and chronic
Serendipity and passion peg an elusive illness
Frontiers in science, technology and medicine
How physicians are fueling the opioid epidemic